Granite Shares Advisors LLC Gilead Sciences, Inc. Transaction History

Granite Shares Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $19,990 - $22,802	-263 Reduced 6.87%	3,564 $274,000
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $1,391 - $1,585	18 Added 0.47%	3,827 $317,000
Q4 2022 Jan 26, 2023	SELL	$62.32 - $89.47 $35,834 - $51,445	-575 Reduced 13.12%	3,809 $0
Q3 2022 Oct 14, 2022	SELL	$59.54 - $68.01 $26,435 - $30,196	-444 Reduced 9.2%	4,384 $270,000
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $55,295 - $62,279	-958 Reduced 16.56%	4,828 $298,000
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $26,990 - $33,822	-466 Reduced 7.45%	5,786 $343,000
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $405,629 - $460,397	6,252 New	6,252 $453,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Shares Advisors LLC with notifications on news.